It did not have a significantly different therapeutic efficacy from the commercial paste dosage form in the treatment of oral lichen planus. Buffering agents and an antioxidant should be added to ...

Treatment: There is no cure for lichen planus ... One in five will have a recurrence of lichen planus. Oral lichen planus with ulceration must be followed meticulously to prevent the development ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Treating lichen planus and oral cancer together can be complex, as both conditions require different treatment approaches. The goal is to manage the symptoms of lichen planus while effectively ...

Currently, there are no FDA-approved pharmacotherapies for Oral Lichen Planus, and LP-310 is the only topical treatment in development for OLP. About the Study The Oral Lichen Planus Clinical ...

Patent application covers key technology innovations for delivering therapeutic agentsProprietary technology enables precise delivery to improve ...

With the recent patent allowance and ongoing clinical trials, Lipella Pharmaceuticals is poised for significant advancements in its therapeutic offerings. The company’s focus on conditions with high ...

Treatment with topical corticosteroids and/or intralesional triamcinolone acetonide ... the present research topic provides an overview of oral involvement in the setting of autoimmune blistering ...

Genital rashes have many different causes, ranging from jock itch and vaginal yeast infections to sexually transmitted infections (STIs) caused by bacteria, viruses, and parasites. Depending on the ...

Lipella Pharmaceuticals’ innovative liposomal drug delivery platform receives US patent: Pittsburgh Wednesday, October 16, 2024, 17:00 Hrs [IST] Lipella Pharmaceuticals Inc., a ...

Syphilis is typically treated with antibiotics. Your healthcare provider will repeat testing after the entire course of treatment is complete. It is important to get tested regularly and to practice ...

With no FDA-approved drug treatments available, LP-10 is positioned to become a breakthrough therapy for patients suffering from this debilitating condition. Oral lichen planus is a chronic ...